» Articles » PMID: 22678420

Determining Mammosphere-forming Potential: Application of the Limiting Dilution Analysis

Overview
Date 2012 Jun 9
PMID 22678420
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Originally adapted from the neurosphere assay, the nonadherent mammosphere assay has been utilized to assess early progenitor/stem cell frequency in a given population of mammary epithelial cells. This method has also been used to measure the frequency of tumorsphere initiating cells in both primary mammary tumors as well as in tumor cell lines. Although, the mammosphere assay has been used extensively in the mammary gland field, a standard method of quantifying and analyzing sphere growth in this assay has remained undefined. Here, we discuss the use and benefit of using a limiting dilution analysis to quantify sphere-forming frequency in primary mammary epithelial cells grown in nonadherent conditions.

Citing Articles

Natural Cyclophilin A Inhibitors Suppress the Growth of Cancer Stem Cells in Non-Small Cell Lung Cancer by Disrupting Crosstalk between CypA/CD147 and EGFR.

Han J, Kim S, Kim H, Cho H, Jung H Int J Mol Sci. 2023; 24(11).

PMID: 37298389 PMC: 10253869. DOI: 10.3390/ijms24119437.


Exploring the Role of Hypoxia-Inducible Carbonic Anhydrase IX (CAIX) in Circulating Tumor Cells (CTCs) of Breast Cancer.

Twomey J, Zhang B Biomedicines. 2023; 11(3).

PMID: 36979915 PMC: 10046014. DOI: 10.3390/biomedicines11030934.


Early Dietary Exposures Epigenetically Program Mammary Cancer Susceptibility through Igf1-Mediated Expansion of the Mammary Stem Cell Compartment.

Zheng Y, Luo L, Lambertz I, Conti C, Fuchs-Young R Cells. 2022; 11(16).

PMID: 36010633 PMC: 9406400. DOI: 10.3390/cells11162558.


Identification, Culture and Targeting of Cancer Stem Cells.

Herreros-Pomares A Life (Basel). 2022; 12(2).

PMID: 35207472 PMC: 8879966. DOI: 10.3390/life12020184.


lncRNA BORG:TRIM28 Complexes Drive Metastatic Progression by Inducing α6 Integrin/CD49f Expression in Breast Cancer Stem Cells.

Parker K, Gooding A, Valadkhan S, Schiemann W Mol Cancer Res. 2021; 19(12):2068-2080.

PMID: 34497119 PMC: 8642309. DOI: 10.1158/1541-7786.MCR-21-0137.


References
1.
Hu Y, Smyth G . ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods. 2009; 347(1-2):70-8. DOI: 10.1016/j.jim.2009.06.008. View

2.
Dontu G, Wicha M . Survival of mammary stem cells in suspension culture: implications for stem cell biology and neoplasia. J Mammary Gland Biol Neoplasia. 2005; 10(1):75-86. DOI: 10.1007/s10911-005-2542-5. View

3.
Molyneux G, Regan J, Smalley M . Mammary stem cells and breast cancer. Cell Mol Life Sci. 2007; 64(24):3248-60. PMC: 11136291. DOI: 10.1007/s00018-007-7391-5. View

4.
Stingl J, Eaves C, Zandieh I, Emerman J . Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res Treat. 2001; 67(2):93-109. DOI: 10.1023/a:1010615124301. View

5.
Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D . Purification and unique properties of mammary epithelial stem cells. Nature. 2006; 439(7079):993-7. DOI: 10.1038/nature04496. View